Story perspectives
Promising Cancer Drug Shows Tumor Disappearance in Trials
8/25/2025
30 6
1 of 1
Story summary
- A clinical trial at Rockefeller University evaluated the re-engineered cancer drug 2141-V11, yielding promising results in 12 patients.
- Complete tumor disappearance occurred in two patients with aggressive melanoma and breast cancer.
- The modified CD40 agonist antibody effectively activated immune responses with mild side effects.
- Systemic tumor reduction beyond injection sites suggests a significant immune response.
